These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 18606464

  • 1. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF.
    Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
    [Abstract] [Full Text] [Related]

  • 2. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
    Talarico LB, Pujol CA, Zibetti RG, Faría PC, Noseda MD, Duarte ME, Damonte EB.
    Antiviral Res; 2005 Jun; 66(2-3):103-10. PubMed ID: 15911027
    [Abstract] [Full Text] [Related]

  • 3. Interference in dengue virus adsorption and uncoating by carrageenans.
    Talarico LB, Damonte EB.
    Virology; 2007 Jul 05; 363(2):473-85. PubMed ID: 17337028
    [Abstract] [Full Text] [Related]

  • 4. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.
    Antivir Ther; 2011 Jul 05; 16(8):1203-18. PubMed ID: 22155902
    [Abstract] [Full Text] [Related]

  • 5. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
    Hidari KI, Ikeda K, Watanabe I, Abe T, Sando A, Itoh Y, Tokiwa H, Morita K, Suzuki T.
    Biochem Biophys Res Commun; 2012 Aug 03; 424(3):573-8. PubMed ID: 22776202
    [Abstract] [Full Text] [Related]

  • 6. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
    Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D.
    Virology; 2009 Apr 25; 387(1):67-75. PubMed ID: 19264337
    [Abstract] [Full Text] [Related]

  • 7. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection.
    Talarico LB, Duarte ME, Zibetti RG, Noseda MD, Damonte EB.
    Planta Med; 2007 Nov 25; 73(14):1464-8. PubMed ID: 17948168
    [Abstract] [Full Text] [Related]

  • 8. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.
    Antiviral Res; 2009 Dec 25; 84(3):234-41. PubMed ID: 19781577
    [Abstract] [Full Text] [Related]

  • 9. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC, Chen NC, Chen PC, Wang CC, Cheng WC, Wu HN.
    Arch Virol; 2012 Apr 25; 157(4):681-8. PubMed ID: 22249364
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
    Kato D, Era S, Watanabe I, Arihara M, Sugiura N, Kimata K, Suzuki Y, Morita K, Hidari KI, Suzuki T.
    Antiviral Res; 2010 Nov 25; 88(2):236-43. PubMed ID: 20851716
    [Abstract] [Full Text] [Related]

  • 11. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT, Liu CH, Li JW, Lin CJ, Jassey A, Wu HN, Perng GC, Yen MH, Lin LT.
    Sci Rep; 2020 Oct 02; 10(1):16378. PubMed ID: 33009425
    [Abstract] [Full Text] [Related]

  • 12. A small molecule fusion inhibitor of dengue virus.
    Poh MK, Yip A, Zhang S, Priestle JP, Ma NL, Smit JM, Wilschut J, Shi PY, Wenk MR, Schul W.
    Antiviral Res; 2009 Dec 02; 84(3):260-6. PubMed ID: 19800368
    [Abstract] [Full Text] [Related]

  • 13. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
    Acosta EG, Piccini LE, Talarico LB, Castilla V, Damonte EB.
    Virus Res; 2014 May 12; 184():39-43. PubMed ID: 24583230
    [Abstract] [Full Text] [Related]

  • 14. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2015 Nov 12; 86(5):1093-104. PubMed ID: 25891143
    [Abstract] [Full Text] [Related]

  • 15. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
    Laosutthipong C, Kanthong N, Flegel TW.
    Antiviral Res; 2013 Jun 12; 98(3):449-56. PubMed ID: 23603496
    [Abstract] [Full Text] [Related]

  • 16. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
    John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P.
    Virus Res; 2019 Jan 15; 260():142-150. PubMed ID: 30508603
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
    Niyomrattanakit P, Chen YL, Dong H, Yin Z, Qing M, Glickman JF, Lin K, Mueller D, Voshol H, Lim JY, Nilar S, Keller TH, Shi PY.
    J Virol; 2010 Jun 15; 84(11):5678-86. PubMed ID: 20237086
    [Abstract] [Full Text] [Related]

  • 18. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M, Liu W, Yuan Z, Gu F, Shi PY.
    Antiviral Res; 2010 May 15; 86(2):163-71. PubMed ID: 20153777
    [Abstract] [Full Text] [Related]

  • 19. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses.
    Lee E, Pavy M, Young N, Freeman C, Lobigs M.
    Antiviral Res; 2006 Jan 15; 69(1):31-8. PubMed ID: 16309754
    [Abstract] [Full Text] [Related]

  • 20. Peptide inhibitors against dengue virus infection.
    Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2014 Aug 15; 84(2):148-57. PubMed ID: 24612829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.